Natco Pharma gets US FDA Form 483 with seven observations at Chennai API unit

Natco Pharma Ltd. said Friday the US Food and Drug Administration has issued a Form 483 with seven observations to its active pharmaceutical ingredients unit at Manali in Chennai, following an inspection conducted between Monday and Friday.

The company said the observations are procedural in nature and it will address them comprehensively